Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions
- PMID: 6542401
Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions
Abstract
A study on mass treatment of Clonorchis sinensis infections with praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin-4-one, EMBAY 8440, Biltricide) was performed in order to find out the most effective and convenient administration scheme of this drug. 3543 (12.3%) out of 28 826 examined individuals were found to be infected with C. sinensis. First, the cellophane thick smear technique was used. Then the infected people were reexamined for determination of EPG (eggs per gram) using Stoll's egg counting technique. Of the infected cases, 2958 individuals were divided into 3 groups and treated with the following three administration schemes of praziquantel: 1. 40 mg/kg X 1 in one day; 2. 30 mg/kg X 2 (total 60 mg/kg) in one day; 3. 30 mg/kg X 3 (total 90 mg/kg) in one day; To evaluate drug efficacy, another stool examination was undertaken 2 months after treatment. Of the treated cases, 2,797 people could be evaluated by both cellophane thick smear and egg counting examinations. The results obtained were as follows: 1. When 40 mg/kg of praziquantel were administered once a day, the cure rate (egg negative conversion rate) was 87.1% and the egg reduction rate was 97.6%. 2. With the dose of 30 mg/kg twice a day with 5-h interval, the cure rate was 94.9% and egg reduction rate was 99.0%. 3. The dosage of 30 mg/kg three times a day with 5-h intervals resulted in 91.4% cure rate and 99.9% egg reduction. The treated cases were reexamined 5 h after drug intake.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Clonorchis sinensis: epidemiology in Taiwan and clinical experience with praziquantel.Arzneimittelforschung. 1984;34(9B):1160-2. Arzneimittelforschung. 1984. PMID: 6391504 Clinical Trial.
-
Clonorchiasis: treatment with praziquantel in 50 cases.Arzneimittelforschung. 1984;34(9B):1162-3. Arzneimittelforschung. 1984. PMID: 6542382
-
Phase III clinical trials with praziquantel in S. japonicum infections in the Philippines.Arzneimittelforschung. 1984;34(9B):1221-3. Arzneimittelforschung. 1984. PMID: 6391506 Clinical Trial.
-
A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.Arzneimittelforschung. 1981;31(3a):538-41. Arzneimittelforschung. 1981. PMID: 7016122 Review.
-
Clonorchiasis in Taiwan.Southeast Asian J Trop Med Public Health. 1991 Dec;22 Suppl:184-5. Southeast Asian J Trop Med Public Health. 1991. PMID: 1822883 Review.
Cited by
-
Therapeutic evaluation of sustained-releasing praziquantel (SRP) for clonorchiasis: phase 1 and 2 clinical studies.Korean J Parasitol. 2006 Dec;44(4):361-6. doi: 10.3347/kjp.2006.44.4.361. Korean J Parasitol. 2006. PMID: 17170578 Free PMC article. Clinical Trial.
-
Praziquantel treatment in trematode and cestode infections: an update.Infect Chemother. 2013 Mar;45(1):32-43. doi: 10.3947/ic.2013.45.1.32. Epub 2013 Mar 29. Infect Chemother. 2013. PMID: 24265948 Free PMC article. Review.
-
Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control.Infect Dis Poverty. 2016 Jul 6;5(1):71. doi: 10.1186/s40249-016-0166-1. Infect Dis Poverty. 2016. PMID: 27384714 Free PMC article. Review.
-
Assessment of control strategies against Clonorchis sinensis infection based on a multi-group dynamic transmission model.PLoS Negl Trop Dis. 2020 Mar 27;14(3):e0008152. doi: 10.1371/journal.pntd.0008152. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32218570 Free PMC article.
-
Anthelmintics. A comparative review of their clinical pharmacology.Drugs. 1997 May;53(5):769-88. doi: 10.2165/00003495-199753050-00004. Drugs. 1997. PMID: 9129865 Review.